During the past decade, Hôpital Trousseau conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 20 clinical trials were completed, i.e. on average, 29% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 17 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Trousseau" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 8 trials, followed by "GERCOR - Multidisciplinary Oncology Cooperative Group" with 8 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored, "UNICANCER" with 6 trials sponsored and "Assistance Publique - Hôpitaux de Paris" with 6 trials sponsored. Other sponsors include 77 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Trousseau" #1 collaborator was "Ministry of Health, France" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "National Cancer Institute, France" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Trousseau" are "Ulcerative Colitis" (6 trials), "Colorectal Cancer" (5 trials), "Heart Failure" (5 trials), "Rheumatoid Arthritis" (4 trials) and "Melanoma" (3 trials). Many other conditions were trialed in "Hôpital Trousseau" in a lesser frequency.

Most popular intervention types in "Hôpital Trousseau" are "Drug" (71 trials), "Other" (20 trials), "Device" (18 trials), "Procedure" (9 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Gemcitabine" (4 trials), "Avelumab" (3 trials), "Oxaliplatin" (3 trials) and "irinotecan hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Trousseau" are 115 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Trousseau". undefined are not yet recruiting, 23 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 60 completed trials in Hôpital Trousseau, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Trousseau, 1 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 17 trials that are defined as “Not Applicable".